Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure 
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
DALLAS, May 01, 2018 -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The new THC infused beverage will expand Puration’s current cannabis infused beverage business. Last year, Puration introduced EVERx, a CBD infused sports water. The sales of EVERx yielded over a 60% gross margin as reported in the company’s 2017 annual report. The initial sales have won the interest of additional distributors to include a recently announced national distribution contract. Puration has designed a THC infused beverage and registered the name THCSavor. Package design is underway. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation scheduled for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
